Stockreport

Aldeyra Therapeutics stock rises 13% on Q2 beat with eyes on approval path for reproxalap [Seeking Alpha]

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations
PDF Aldeyra Therapeutics stock rises 13% on Q2 beat with eyes on approval path for reproxalapAug. 05, 2022 12:21 PM ETAldeyra Therapeutics, Inc. (ALDX)By:RavikashSA News Edi [Read more]